Stock Events

Stock Events

Avalo Therapeutics (C6K0.F) Q2 2024 Earnings

13MayConfirmed

Q2 2024

-130.63

-87.45

-44.27

-1.09

Details

Expected EPS

-1.0932464

Actual EPS

-130.63368

Surprise EPS

-129.54

Surprise Percent

+11,849.15%

Description

Avalo Therapeutics (C6K0.F) has reported earnings of -130.63368 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.